Vivien Jiaqian Zhu | Humanities | Best Researcher Award

Dr. Vivien Jiaqian Zhu | Humanities | Best Researcher Award

PhD at Stanford University and University of California, Berkeley, United States.

Vivien Jiaqian Zhu is a Ph.D. candidate at UC Berkeley and a visiting scholar at Stanford University, specializing in Japanese literature and art history. She has a diverse academic background, with studies spanning multiple prestigious institutions such as Harvard, Stanford, and Cambridge. Zhu’s research primarily focuses on East Asian languages and cultures, particularly on topics related to Japanese literature, art history, and the intersection of textuality and haptic aesthetics. She has demonstrated excellence through various honors, fellowships, and academic experiences, including her dissertation on the haptic beauty in Kawabata Yasunari’s works. Zhu has also presented at numerous international conferences and contributed significantly to the field through archival research, publications, and curatorial work.

Publication Profile

Orcid

Education 🎓

Vivien Jiaqian Zhu has pursued a diverse academic path across prestigious institutions. She is currently a Ph.D. candidate in Japanese Language and Literature at UC Berkeley, where she also received the Regent’s Fellowship. Her Master’s thesis focuses on Kawabata Yasunari’s works, exploring the tactile beauty in his Palm-of-the-Hand Stories. Zhu’s undergraduate studies at UC Berkeley culminated in an honors degree in Comparative Literature and Chinese Language, with a minor in the History of Art. She earned Phi Beta Kappa and other honors during her time at Berkeley. Zhu also studied advanced Japanese at the Inter-University Center for Japanese Language Studies in Yokohama and undertook language programs at Sophia University, Japan. Her academic pursuits also took her to Middlebury College and the Culinary Institute of America. At present, she is also studying Early Modern Japanese Palaeography at the University of Cambridge under the Mitsubishi Research Fellowship.

Experience 🩺

Vivien Jiaqian Zhu has accumulated extensive experience through her academic and professional roles. She is a visiting scholar at Stanford University, where she collaborates on research projects and participates in academic seminars. Zhu has also worked as a graduate student researcher at UC Berkeley, where she assisted in archival research and curated collections, focusing on Japanese literature and East Asian cultures. Her professional experience extends to editorial roles, including serving on the editorial board of the International Journal of Sustainable Fashion & Textile and as the editor of the Language & Theory section of Ling Mag. Zhu’s expertise is also reflected in her involvement in the International Joint Digital Center for Japanese Art and Culture at Ritsumeikan University. She has conducted research across various international libraries, including UC Berkeley, Nanjing University, and the University of Tokyo. Additionally, Zhu has gained teaching experience, particularly in Chinese calligraphy and East Asian studies.

Awards and Honors 🏅

Vivien Jiaqian Zhu’s academic excellence has been recognized through numerous prestigious awards and fellowships. In 2024, she received the Mitsubishi Research Fellowship for Early Modern Japanese Palaeography at the University of Cambridge, allowing her to study under the Emmanuel College at the university. Zhu has been honored with the Regent’s Fellowship for Graduate Study at UC Berkeley, nominated by Professor H. Mack Horton. She was awarded the CJS Graduate Student Fellowship, the UC Berkeley Departmental Award, and the Theresa Hak Kyung Cha Fellowship Award. Zhu’s academic recognition extends to memberships in Phi Beta Kappa and Golden Key International Honor Society. She has also earned multiple scholarships and fellowships, including the Nippon Foundation Fellowship for Japanese language studies at Stanford, the Dietrich von Bothmer Classical Scholarship, and the Institute of International Studies Undergraduate Merit Scholarship. Her research contributions have been consistently acknowledged, making her a prominent figure in East Asian literary studies.

Research Focus 🔬

Vivien Jiaqian Zhu’s research focuses on the intersection of Japanese literature, art history, and East Asian cultural studies. Her doctoral research at UC Berkeley explores the tactile and haptic elements in Kawabata Yasunari’s Palm-of-the-Hand Stories, examining how sensory experiences influence narrative structure and reader engagement. Zhu’s academic interests include the cultural and historical contexts of Japanese literature, with a particular emphasis on modern and early modern periods. She investigates the transnational connections between Japan, China, and the broader East Asian region, often incorporating interdisciplinary methodologies from comparative literature, art history, and cultural studies. Additionally, Zhu has worked on archival research projects, including studies of Chinese calligraphy, criminal law, and comparative law. Her studies in early modern Japanese palaeography and her deep engagement with East Asian art and literature reflect her broad intellectual interests, positioning her as a key scholar in understanding the intricate relationships between language, culture, and history in the region.

Conclusion

Vivien Jiaqian Zhu is an exceptionally talented researcher whose interdisciplinary approach and scholarly achievements make her an outstanding candidate for the Best Researcher Award. Her unique focus on the tactile aesthetics in Japanese literature and art, along with her academic excellence, make her stand out as a leader in her field. With a proven track record of global recognition and a commitment to advancing knowledge, Zhu’s continued contributions will undoubtedly have a lasting impact on the study of East Asian literature and art history.

Publication Top Notes 📚

  • “I Dwell in Possibility”: The Poetics of Space in the Works of 1980s Japanese Avant-Garde Fashion DesignersComparative Literature: East & West

    2024-12-08 | journal-article

    Source:Crossref

    DOI: 10.1080/25723618.2024.2433301

 

Hawraa Shbeeb | Medicine | Best Researcher Award

Dr. Hawraa Shbeeb | Medicine | Best Researcher Award

Fellowship in Infertility and IVF at Tehran University of Medical Sciences, Iran, Iran.

Dr. Hawraa Shbeeb is a dedicated Obstetrics and Gynecology Specialist currently pursuing a Fellowship in Infertility and IVF at Tehran University of Medical Sciences. She has significant international experience, registered as a specialist in both Iran and Lebanon, and is affiliated with several esteemed organizations like the Lebanese Society of Obstetrics and Gynecology (LSOG) and ISUGO. Her certifications demonstrate a commitment to continuous medical education, and she has contributed to research in infertility and reproductive health, with a recent publication in a peer-reviewed journal.

Publication Profile

Orcid

Education 🎓

Dr. Hawraa Shbeeb earned her Doctor of Medicine (MD) degree from Mashhad University of Medical Sciences (2009-2017). She specialized in Obstetrics and Gynecology at the same institution, completing her residency in December 2021. Currently, she is advancing her expertise through a Fellowship in Infertility and IVF at the prestigious Tehran University of Medical Sciences (2023-present). Her educational background also includes passing the Lebanese Colloquium Medicine Exam (2022), enabling her to practice in Lebanon. Her academic journey reflects a strong focus on women’s reproductive health, with an emphasis on infertility, assisted reproductive technologies, and high-risk pregnancies. Dr. Shbeeb’s pursuit of advanced certifications and continuous learning underscores her dedication to providing cutting-edge care in the field of reproductive medicine.

Experience 🩺

Dr. Hawraa Shbeeb has extensive experience as an Obstetrics and Gynecology Specialist. She has been practicing at the Imam Khomeini Hospital Complex in Tehran since January 2023. Previously, she served at the Imam Reza Hospital and Ghaem and Ommolbanin Hospitals in Mashhad, Iran (2017-2020). Dr. Shbeeb is also registered with the Lebanese Order of Physicians (LOP) and has been an active specialist in Lebanon since October 2022. Her affiliations with professional organizations like LSOG and ISUGO highlight her involvement in the global medical community. Additionally, she is a dedicated volunteer with the Iranian Red Crescent (2024-present), contributing to humanitarian efforts. Her experience spans clinical practice, research, and teaching, demonstrating a holistic approach to women’s healthcare.

Awards and Honors 🏅

Dr. Hawraa Shbeeb has earned multiple accolades for her contributions to healthcare and continuous education. She received the International Volunteer Day Award from the Iranian Red Crescent for her humanitarian work in Khorasan Razavi. Her certifications from esteemed bodies like ACOG, SAFOG, FOGSI, and the American Association for Continuous Education reflect her commitment to excellence in gynecology and reproductive health. Notable certifications include those in Minimal Access Surgery, Infertility & ARTs, Pregnancy Complications, and Fetal Medicine. She also holds certifications in Advanced Cardiac Life Support (ACLS), Pediatric Advanced Life Support (PALS), and Basic Life Support (BLS) from Medtigo Health Education. These honors underscore her dedication to patient care, continuous learning, and professional excellence.

Research Focus 🔬

Dr. Hawraa Shbeeb’s research focuses on the fields of infertility, assisted reproductive technology (ART), and high-risk pregnancies. Her work addresses rare and complex gynecological cases, particularly those involving ectopic pregnancies and complications arising from embryo transfer procedures. Through her recent fellowship, she delves into advanced infertility treatments, IVF protocols, and improving outcomes for couples facing reproductive challenges. Dr. Shbeeb is dedicated to exploring new frontiers in minimal-access gynecological surgery, fetal medicine, and pregnancy complications. Her goal is to bridge clinical practice and research to enhance patient care. Her published case report on cornual pregnancy highlights her commitment to identifying and addressing rare medical conditions, providing valuable insights to the medical community.

Conclusion

Dr. Hawraa Shbeeb is a strong candidate for the Best Researcher Award due to her extensive clinical expertise, dedication to infertility research, and international professional affiliations. Her recent publication and ongoing fellowship in IVF indicate active engagement with cutting-edge reproductive medicine. Strengthening her research output and focusing on collaborative projects can further solidify her standing as a distinguished researcher in her field.

Publication Top Notes 📚

  • Title: Cornual Pregnancy as a Rare Entity of Ectopic Pregnancy After Assisted Reproductive Therapy‐Embryo Transfer (ART‐ET): A Case ReportPublication: Clinical Case Reports
    Year: 2024
    ISSN: 2050-0904Authors: Hawraa Hassan Shbeeb

 

 

Xiaoning wang | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Xiaoning wang | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Xiaoning wang, Department of Hematology, The First Affiliated Hospital of Xi’an Jiaotong University, China

Dr. Xiaoning Wang serves as the Deputy Director at The First Affiliated Hospital of Xi’an Jiaotong University. With over 17 years of medical expertise, Dr. Wang is an Associate Chief Physician specializing in hematopoietic stem cell transplantation and immunotherapy. 🧬✨ He has led notable research projects, including advancements in acute T-cell leukemia treatment and NK cell reconstruction. Dr. Wang has published extensively in renowned journals like Blood and Nature Communications 🩸📚 and holds multiple patents. A leader in the field, he is a key figure in various medical associations, driving innovation and collaboration in hematology. 🌐🎓

 

Publication Profile

Orcid

Academic and Professional Background 🎓💼

Assoc. Prof. Dr. Xiaoning Wang has a rich medical career spanning over 17 years. He currently serves as an Associate Chief Physician (Jan 2017 – Present), where he oversees advanced hematology treatments and research. Previously, he worked as an Attending Physician (Mar 2012 – Dec 2016), gaining extensive expertise in patient care and clinical decision-making. His medical journey began as a Resident Doctor (July 2006 – Feb 2012), where he honed his foundational skills in diagnostics and treatment. Dr. Wang’s professional growth reflects his dedication to medical excellence and patient-focused innovation. 🏥🩺✨

 

Research Contributions

Assoc. Prof. Dr. Xiaoning Wang is a prominent researcher whose work spans hematology, oncology, and infectious diseases. Key studies include identifying the novel HLA-C*14:02:01:33 allele via advanced sequencing techniques, optimizing treatment regimens for severe pneumocystis pneumonia, and investigating high NK cell levels in grafts reducing febrile neutropenia post-transplantation. Her pivotal work on molecular biomarkers in multiple myeloma and graft-versus-host disease therapies showcases her innovative approach to immunology and stem cell research. Dr. Wang has significantly contributed to international medical knowledge, with publications in Nature Communications, Blood, and JAMA Ophthalmology. 📚✨

Publication Top Notes 📚

  • The novel HLA-C*14:02:01:33 allele identified by Pacific Biosciences HiFi sequencing in a Chinese individual.
  • A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital.
  • Endogenous Aspergillus thermomutatus Endophthalmitis in a Patient With Myelodysplastic Syndrome.
  • High levels of NK Cells in graft are associated with reduced febrile neutropenia after haploidentical peripheral blood stem cell transplantation.
  • The latest edition of WHO and ELN guidance and a new risk model for Chinese acute myeloid leukemia patients.
  • Bloody tears as initial manifestation of rhino-orbital mucormycosis.
  • Pneumocystis jiroveci Pneumonia secondary to tyrosine kinase inhibitor with blinatumomab therapy: A case report.
  • ADAR1 improved Treg cell function through the miR-21b/Foxp3 axis and inhibits the progression of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
  • Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils Novel Prognostic Biomarkers in Multiple Myeloma.
  • Acute myeloid leukemia secondary to acute B lymphoblastic leukemia treated with maintenance therapy in a child: A case report.
  • Basiliximab for steroid-refractory acute graft-versus-host disease: A real-world analysis.

 

Francesca Borgnis | Teleriabilitazione | Best Researcher Award

Dr. Francesca Borgnis | Teleriabilitazione | Best Researcher Award

Dr. Francesca Borgnis, IRCCS Fondazione Don Carlo Gnocchi ONLUS, Italy

Dr. Francesca Borgnis is a distinguished Italian researcher specializing in psychology, telerehabilitation, and digital health interventions. She earned her Ph.D. in Psychology from the Catholic University of Sacred Heart, Italy (2019–2023), and currently serves as a researcher at the S. Maria Nascente IRCCS Fondazione Don Carlo Gnocchi ONLUS. Her work focuses on innovative treatments, including digital therapeutics for chronic neurological disorders, and she has collaborated on numerous grants and projects, such as SIDERA^B and DANCEREX. Dr. Borgnis has authored 31 publications, contributing significantly to cognitive rehabilitation, telerehabilitation, and assistive technology research. She also lectures on developmental and educational psychology at Università degli Studi di Milano. 🌐🧠📚

 

Publication Profile

Orcid

Google Scholar

Academic Journey

Dr. Francesca Borgnis is a dedicated scholar with extensive expertise in psychology. She earned her Ph.D. in Psychology from the Catholic University of Sacred Heart, Italy (2019–2023). Before this, she qualified in Psychology through the University of Pavia in 2018. Dr. Borgnis gained valuable clinical experience during her internship at the MRI Lab & Neuropsychology Clinic at S. Maria Nascente, IRCCS Fondazione Don Carlo Gnocchi ONLUS, Italy. She holds a Master’s degree in Clinical, Developmental Psychology, and Neuropsychology (2017) and a Bachelor’s in Psychology (2015), both from the University of Milan-Bicocca. 🧠📚

 

Teaching Activities

Dr. Francesca Borgnis is an accomplished lecturer specializing in developmental and educational psychology. Since 2023, she has been sharing her expertise with students at Università degli Studi di Milano, Italy. Her teaching focuses on fostering a deep understanding of psychological development and its applications in educational settings. With a passion for empowering future professionals, Dr. Borgnis integrates her academic and clinical experience into engaging and insightful lectures. Her dedication to teaching reflects her commitment to advancing knowledge in psychology and inspiring the next generation of scholars. 🎓👩‍🏫

 

Professional Engagements

Dr. Francesca Borgnis actively contributes to the academic and research community through her role as a Member of the Advisory Board Giovani Ricercatori at Fondazione Don Gnocchi ONLUS, a position she has held since 2024. In this capacity, she collaborates with fellow researchers to foster innovation and support young investigators in their academic journeys. Dr. Borgnis is dedicated to building networks within scientific societies and promoting interdisciplinary collaboration. Her involvement in this advisory role underscores her commitment to advancing research excellence and nurturing the next generation of scholars. 🤝🧠✨

 

🎯 Research Focus

Dr. Francesca Borgnis specializes in innovative approaches to cognitive and neuropsychological assessment, with a strong emphasis on virtual reality (VR) and telerehabilitation. Her research explores the role of mirror neurons in neurodegenerative disorders 🧠, VR-based tools for evaluating executive functions 🎮, and the use of 360° technology for memory and cognitive assessments. Dr. Borgnis has contributed to studies on Parkinson’s disease, Alzheimer’s disease, and chronic disabilities, focusing on digital health interventions and assistive technologies 🤖. Her work integrates systematic reviews, meta-analyses, and cutting-edge methodologies to enhance patient rehabilitation and assessment in clinical neuropsychology. ✨📊

 

Publication Top Notes  

📚 Mirror neurons and their relationship with neurodegenerative disorders
🖋️ E Farina, F Borgnis, T Pozzo
📅 2020 | 🔗 Cited by: 49

🌐 Available virtual reality-based tools for executive functions: a systematic review
🖋️ F Borgnis, F Baglio, E Pedroli, et al.
📅 2022 | 🔗 Cited by: 45

🧠 The use of a virtual reality platform for memory decline and hippocampal neural injury in mild cognitive impairment
🖋️ M Cabinio, F Rossetto, S Isernia, et al.
📅 2020 | 🔗 Cited by: 35

💻 Telerehabilitation approaches for chronic heart failure: a systematic review and meta-analysis
🖋️ S Isernia, C Pagliari, N Morici, et al.
📅 2022 | 🔗 Cited by: 20

🌬️ Characteristics and efficacy of telerehabilitation for chronic obstructive pulmonary disease
🖋️ S Isernia, C Pagliari, LNC Bianchi, et al.
📅 2022 | 🔗 Cited by: 19

🧪 Digital health intervention for Alzheimer’s disease: Ability-TelerehABILITation trial
🖋️ F Rossetto, S Isernia, F Borgnis, et al.
📅 2023 | 🔗 Cited by: 15

🚀 Executive-functions innovative tool (EXIT 360): Usability and user experience study
🖋️ F Borgnis, F Baglio, E Pedroli, et al.
📅 2021 | 🔗 Cited by: 14

🎥 A simple and effective way to study executive functions using 360 videos
🖋️ F Borgnis, F Baglio, E Pedroli, et al.
📅 2021 | 🔗 Cited by: 14

🛠️ System Integrated Digital Empowering and TeleRehabilitation (SIDERA): Usability and acceptability study
🖋️ F Rossetto, F Borgnis, S Isernia, et al.
📅 2023 | 🔗 Cited by: 13

🏃 Functional improvement after multidisciplinary rehabilitation in Parkinson’s disease
🖋️ M Meloni, FL Saibene, S Di Tella, et al.
📅 2021 | 🔗 Cited by: 13

🎼 Modified graded motor imagery for musicians’ focal dystonia: a case series
🖋️ M Ramella, F Borgnis, et al.
📅 2021 | 🔗 Cited by: 13

📝 SIDERA^B Protocol: Randomized trial on digital health and rehabilitation
🖋️ F Rossetto, F Borgnis, et al.
📅 2022 | 🔗 Cited by: 10

Ashwani Singal | Medicine and Dentistry | Best Researcher Award

Ashwani Singal | Medicine  and Dentistry | Best Researcher Award

Prof Ashwani Singal, University of Louisville School of Medicine, United States

Prof. Ashwani Singal, he appears to be a highly suitable candidate for the Best Researcher Award. Here are several reasons supporting this nomination:

Publication Profile

Google Scholar

Research and Academic Excellence

  • Extensive Education: Prof. Singal holds an MBBS, MD in Medicine, and a DM in Gastroenterology, along with postdoctoral training in Transplant Hepatology and Gastroenterology from prestigious institutions like Mayo Clinic and UTMB Galveston.
  • Publications: He has a substantial publication record, including influential papers on liver diseases, alcoholic liver disease, and hepatitis C, demonstrating his contributions to advancing medical knowledge in his field. His work has been recognized in reputable journals and conferences, with multiple posters of distinction presented at AASLD annual conferences.

Clinical Impact

  • Leadership Roles: As the Medical Director of Liver Transplant at the Trager Transplant Institute and a Transplant Hepatologist at Avera Transplant Institute, he plays a critical role in clinical practice and patient care, impacting many lives.
  • Current Support: His involvement in multiple funded research projects indicates ongoing commitment to advancing research in alcohol use disorders and liver diseases, with significant financial backing from NIH and other organizations.

Contributions to Medical Education

  • Teaching and Mentoring: Prof. Singal has extensive experience in teaching medical students and residents across various institutions, having served as a course director and providing numerous lectures and grand rounds. His mentorship has led to several mentees receiving awards for their research.

Professional Engagement

  • Committee Involvement: He has served on numerous committees and councils within professional societies, showcasing his dedication to improving the field of gastroenterology and hepatology.
  • Editorial Roles: Prof. Singal is active in the editorial boards of reputable journals, contributing to the peer-review process and shaping future research directions in his specialty.

Recognition and Awards

  • Recent Nominations: His nomination for the Clinical Innovation Award by the Healio-American College of Gastroenterology and his status as an International Fellow of the National Academy of Medical Science in India highlight his recognition as a leader in his field.

Publication Top Notes

ACG clinical guideline: alcoholic liver disease

The Bioenergetic Health Index: a new concept in mitochondrial translational research

Evolving frequency and outcomes of liver transplantation based on etiology of liver disease

Antioxidants as therapeutic agents for liver disease

Hepatitis C virus and hepatocellular carcinoma: a narrative review

Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus–related cirrhosis

Mesenteric venous thrombosis

 

Conclusion

Prof. Ashwani Singal’s extensive academic credentials, significant clinical contributions, commitment to education, active engagement in professional societies, and recognition in the form of awards and nominations make him an exemplary candidate for the Best Researcher Award. His work not only contributes to advancing medical knowledge but also directly impacts patient care and the training of future healthcare professionals.

Hironori Tsujimoto | Medicine and Dentistry | Best Researcher Award

Hironori Tsujimoto | Medicine and Dentistry | Best Researcher Award

Prof Dr Hironori Tsujimoto National Defense Medical College, Japan

Prof. Dr. Hironori Tsujimoto’s education, professional experience, and research publications, he is indeed a strong candidate for the Best Researcher Award. His research in upper-gastrointestinal surgery, oncology, and innovative therapeutic techniques demonstrates significant contributions to the field. Below is a breakdown of his qualifications:

Publiacation Profile

orcid

Educational Background and Professional Experience

Prof. Dr. Tsujimoto graduated from the National Defense Medical College in 1993, completed his residency, and advanced his career through post-doctoral studies at both National Defense Medical College and the University of Florida. Since 2007, he has held key positions, including Assistant Professor and Director of Upper-gastrointestinal Surgery, contributing extensively to both surgical practice and research.

Research Contributions

Prof. Tsujimoto has consistently focused on cancer research, especially in gastrointestinal malignancies, lymph node metastasis, and therapeutic innovations. His research output, including publications in top journals, underscores his influence in the field. Some highlights include the study on high mobility group box chromosomal protein 1 expression in esophageal squamous cell carcinoma, published in Journal of Gastroenterology and Hepatology (2020). This work showed how perioperative protein levels impact long-term outcomes in cancer patients, advancing clinical management practices.

Membership

Prof. Tsujimoto is an active member of several prestigious medical organizations in Japan. These include the Japanese Surgical Society, the Japanese Society of Gastroenterological Surgery, and the Japanese Society for Clinical Surgery. Dr. [Name] also contributes to the Japanese Society for Surgical Metabolism and Nutrition, the Japan Shock Society, and the Japan Society for Endoscopic Surgery. Through these memberships, they stay at the forefront of surgical innovation and patient care, enhancing their expertise and contributing to the medical community.

Research

From 1993 to 2000, I served as a Research Associate at the Department of Surgery I, National Defense Medical College, under the guidance of Professor Mochizuki H. Since 2000, I have continued as a Research Associate at the same institution, now working in the Department of Surgery alongside Professor Hase K., with additional supervision by Professor Seki S. from the Department of Immunology and Microbiology. My research spans over two decades, contributing to advancements in surgical and immunological fields.

Publication Top Notes

Significance of resected stomach measurements in postoperative delayed gastric emptying following laparoscopic pylorus‐preserving gastrectom

ASO Author Reflections: Development and Validation Study of the Prognostic Impact of Deep Learning-Determined Myxoid Stroma After Neoadjuvant Chemotherapy in Patients with Esophageal Squamous Cell Carcinoma

Pivotal role of myeloid‐derived suppressor cells in infection‐related tumor growth

Postoperative complications and impaired long‐term survival—Is this causation or association?

Bacterial Translocation in Gastrointestinal Cancers and Cancer Treatment

Conclusion

Prof. Dr. Hironori Tsujimoto’s contributions to surgical oncology and innovative cancer treatments underscore his suitability for the Best Researcher Award. His pioneering work on photodynamic therapy, novel surgical techniques, and understanding of cancer progression significantly advances gastrointestinal surgery and cancer care.

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Dr Cristina Papayannidis, IRCCS, Azienda Ospedaliero Universitaria S.Orsola Malpighi, Bologna, Italy, Italy

Dr. Cristina Papayannidis appears to be an outstanding candidate for the Best Researcher Award based on several key criteria:

Publication profile

scopus

Extensive Experience

Dr. Papayannidis has been deeply involved in clinical research and patient care in hematology since her early career. Her role as Dirigente Medico Ematologia at IRCCS Azienda Ospedaliero Universitaria di Bologna highlights her leadership in AML and ALL clinical trials.

High Research Output

She has authored over 130 publications and has been a principal or sub-investigator in more than 60 phase 1-3 clinical trials, showcasing her significant contributions to advancing hematology research.

Recognition and Influence

With an H-index of 34, she has made substantial impacts in her field. Her role as a speaker at over 300 national and international events, including prestigious conferences like ASH and EHA, underscores her influential presence in the hematological community.

Mentorship and Leadership

Her positions as a mentor in EHA Master Classes and member of various working groups demonstrate her commitment to guiding the next generation of researchers and shaping the future of hematology.

Professional Memberships

  1. Memberships in esteemed organizations such as SIE, EHA, and AACR, and her role on the Hematological Malignancies Committee ESMO further reflect her prominent status and active participation in the scientific community.

Dr. Papayannidis’s extensive research experience, high publication volume, significant impact on clinical practice, and active involvement in mentorship and professional societies make her a highly suitable candidate for the Best Researcher Award.

 

Research focus
The research focus of the individuals associated with these articles centers on hematological malignancies and their management. They investigate advanced treatments and strategies for diseases like acute lymphoblastic leukemia (ALL), particularly in the context of drug therapies and stem cell transplantation. Key topics include evaluating the efficacy of ponatinib versus imatinib in treating Philadelphia chromosome-positive ALL, using ponatinib to prevent relapse after transplantation, and assessing the impact of inotuzumab ozogamicin on outcomes and complications in refractory cases. Their work contributes to improving therapeutic approaches and patient outcomes in hematology. 🩺💉🔬

Publication top notes

Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)

Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission †

Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Dr Jianglan Long,Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University,China

Dr. Jianglan Long is a dedicated Researcher Intern at Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital and Capital Medical University. Specializing in intelligent molecular diagnostics and drug intervention mechanisms for pre-diabetes and type 2 diabetes, Dr. Long has published several impactful papers. Notable works include studies in International Journal of Biological Macromolecules (2024) on innovative diabetes treatments, and contributions to Diabetes Obesity & Metabolism (2024) on predictive biomarker profiling. Dr. Long is a pioneer in developing integrated diagnostic tools and advancing diabetes treatment in China. 🌟🔬📚

Publication profile

Scopus

Academic and Professional Background

Dr. Jianglan Long is a prominent researcher based at the Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital, Capital Medical University. His primary focus lies in the exploration of intelligent molecular diagnosis and drug intervention mechanisms for prediabetes and type 2 diabetes. Dr. Jianglan Long has made significant contributions to this field, evidenced by his publications in reputable journals such as the International Journal of Biological Macromolecules (2024), Diabetes Obesity & Metabolism (2024), Clinical and Translational Medicine (2021), BMC Endocrine Disorders (2020), and Rapid Communications in Mass Spectrometry (2020), where he served as the first author.

 

Research focus

Category: Research Focus on Intelligent Molecular Diagnosis and Drug Intervention for Diabetes

Jianglan Long’s research centers on advancing the field of intelligent molecular diagnostics and drug interventions for pre-diabetes and type 2 diabetes. Her work includes pioneering biomarker profiling for early disease detection and the enhancement of metformin therapy with innovative treatments, like low molecular weight polysaccharides from Astragalus membranaceus. With twelve published journals and ongoing research, her contributions are crucial for improving diabetes management and treatment outcomes in China and potentially worldwide. 📊🔬💊🌍

Publication top notes

Structural characterization of Astragalus polysaccharide-D1 and its improvement of low-dose metformin effect by enriching Staphylococcus lentus

Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation

Rapid multichannel fluorescent probe assay for CYP450 inhibition screening and drug interaction monitoring

Novel weight loss diet attenuates dietary-induced obesity in mice and might correlate with altered gut microbiota and metabolite profiles

Polystyrene microplastic exposure induces insulin resistance in mice via dysbacteriosis and pro-inflammation

Evaluation of interaction of chlorogenic acid and cefotaxime sodium based on sequential analysis

Network pharmacology-based dissection of the underlying mechanisms of dyspnoea induced by zedoary turmeric oil

Metabolomics based plasma biomarkers for diagnosis of oral squamous cell carcinoma and oral erosive lichen planus

Dan Yan | Medicine and Dentistry | Best Researcher Award

Dan Yan | Medicine and Dentistry | Best Researcher Award 

Prof Dan Yan,Beijing Friendship Hospital, Capital Medical University,China

Prof. Dan Yan, Ph.D., is a leading figure in clinical pharmacy and precision medicine at Beijing Institute of Clinical Pharmacy, China. 🌟 With a robust background in traditional Chinese medicine and a Ph.D. from Chengdu University, he specializes in intelligent molecular diagnosis and combined medication for chronic metabolic diseases. 🧬 His groundbreaking research focuses on optimizing diabetes treatment, particularly exploring multi-drug combinations and personalized therapies. As a prolific author and committee member of prestigious scientific organizations, Prof. Yan is dedicated to advancing healthcare through innovative research and evidence-based practices. 📚✨

Publication profile

Scopus

Education

Prof. Dan Yan pursued an extensive educational journey at Chengdu University of Traditional Chinese Medicine, culminating in a Ph.D. from 2004 to 2007. Prior to his doctoral studies, he obtained his Master of Science degree from the same institution between 2001 and 2004. Prof. Yan’s academic pursuits trace back to his undergraduate years, where he completed his Bachelor of Science degree from 1994 to 1998, laying the foundation for his subsequent advanced studies. His educational background reflects a dedicated commitment to traditional Chinese medicine, fostering a deep expertise in this field.

Research focus

Prof. Dan Yan’s research focuses on the intelligent molecular diagnosis and combined medication for chronic metabolic diseases, particularly pre-diabetes and type 2 diabetes. His work leverages multi-omics approaches, such as metabolomics, to enhance early diagnosis and personalized treatment strategies. He aims to optimize drug combinations from a broad range of hypoglycemic drugs, including traditional and novel therapies. This research not only addresses the declining efficacy of long-term metformin use but also integrates pharmacoeconomics and evidence-based medicine to improve clinical outcomes in diabetes care.

 

Publication top notes

Structural characterization of Astragalus polysaccharide-D1 and its improvement of low-dose metformin effect by enriching Staphylococcus lentus

A systematic review on the appropriate discounting rates for the economic evaluation of gene therapies: Whether a specific approach is justified to tackle the challenges?

Antibiotic combinations prediction based on machine learning to multicentre clinical data and drug interaction correlation

Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation

Rapid multichannel fluorescent probe assay for CYP450 inhibition screening and drug interaction monitoring

QALY-type preference and willingness-to-pay among end-of-life patients with cancer treatments: a pilot study using discrete choice experiment

β-Elemene in zedoary turmeric oil injection induces dyspnea by binding to hemoglobin and upregulating HIF-1α

Predicting coronary heart disease in Chinese diabetics using machine learning

Editorial: Benefits and risks of drug combination therapy for chronic metabolic diseases

Quality assessment and control of Shuanghuanglian Lyophilized Injection based on cell response spectrum 

Eman Helmy Ahmed Abdelmonaim | Pharmaceutical Sector Award | Women Researcher Award

Dr. Eman Helmy Ahmed Abdelmonaim | Pharmaceutical Sector Award | Women Researcher Award

Dr. Eman Helmy Ahmed Abdelmonaim, National Research Centre NRC, Egypt

Eman Helmy Ahmed Abdelmonaim is an accomplished Egyptian researcher specializing in polymer science and nanotechnology. With a Ph.D. in Chemistry, she has conducted extensive research and received recognition for her work, including prestigious fellowships and awards. Her expertise spans various fields, from organic chemistry to spectroscopic techniques. Eman has contributed significantly to scientific conferences and publications, showcasing her innovative contributions to the field. With a passion for learning and a resilient attitude, she continues to excel in her endeavors, aiming to make impactful contributions to the scientific community. 🧪🔬

 

Publication Profile

Google Scholar

Education and Qualification 

Eman Helmy pursued her academic journey with dedication, starting from Al-Azhar Language School for her high school education in Nasr City, Egypt. She then obtained her Bachelor of Science degree in Special Chemistry from Al Azhar University, graduating with distinction in 2005. Her passion for organic chemistry led her to pursue further studies, culminating in a Master’s degree in Organic Chemistry from Cairo University in 2014. Her research focus on the preparation and characterization of polymeric nanocomposites earned her acclaim, with her thesis being examined by Prof. Dr. Patricia Heiden from Michigan Technological University, USA. In 2019, she successfully completed her Ph.D. in Chemistry, delving into the preparation of polymeric materials embedded in nano-structured oxides through joint supervision from Ain Shams University, Egypt, and Siegen University, Germany. 📚🎓

 

Research Focus

Eman Helmy Ahmed’s research focus revolves around the synthesis and characterization of advanced nanocomposites for various applications, particularly in dielectric materials and optical waveguide technologies. Her work encompasses the preparation and evaluation of hyperbranched polymers embedded with nanoparticles like montmorillonite clay and phosphosilicate, aiming at enhancing their dielectric and optical properties. Through her investigations, she explores the potential of these materials in fields such as electrical applications, planar optical waveguides, and friction coefficient modulation. Eman’s dedication to advancing nanotechnology contributes significantly to the development of innovative solutions for industrial and scientific challenges. 🔬✨